Xiaflex 0.9MG pwvl 1S
Ended Awarded
- Contract number
- SPE2DR26FBUKE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,423
Award facts
- Contract value 100% obligated
- $40,422.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $40,422.71 delivery order to DMS Pharmaceutical Group Inc. on June 16, 2026, for Xiaflex 0.9 mg powder vial under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The order is firm fixed price with an ultimate completion date of June 29, 2026.
DMS Pharmaceutical Group Inc. is a woman-owned small business headquartered in Park Ridge, Illinois, serving as the regional prime vendor under PPV-G GEN V's $30.3 billion acquisition strategy. Place of performance is Park Ridge, IL.
Quick answers
Who was awarded contract SPE2DR26FBUKE?
SPE2DR26FBUKE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 16, 2026.
How much is contract SPE2DR26FBUKE worth?
The government has obligated $40,423 on SPE2DR26FBUKE.
Is contract SPE2DR26FBUKE an order under another contract?
Yes. SPE2DR26FBUKE is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBUKE competed?
The extent of competition for SPE2DR26FBUKE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award